Intensity Therapeutics Analyst Ratings
Intensity Therapeutics Analyst Ratings
Intensity Therapeutics Analyst Ratings
Benchmark Reiterates Speculative Buy on Intensity Therapeutics, Maintains $12 Price Target
Intensity Therapeutics Analyst Ratings
Benchmark Reiterates Speculative Buy on Intensity Therapeutics, Maintains $12 Price Target
Intensity Therapeutics Analyst Ratings
Benchmark Initiates Coverage On Intensity Therapeutics With Speculative Buy Rating, Announces Price Target of $12
Intensity Therapeutics Analyst Ratings
No Data
No Data